Who owns LIXTE BIOTECHNOLOGY HOLDINGS?

Tip: Access positions for across all investors

Analyze quarterly positions in Lixte Biotechnology Holdings with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lixte Biotechnology Holdings stock

Who bought or sold LIXTE BIOTECHNOLOGY HOLDINGS this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Legacy Wealth Managment 601k $4.5M 100% Jun 2026
 View chart
Vanguard Capital Management 556k $4.1M 1023% Jun 2026
 View chart
Scotia Capital 283k $2.1M 0% Jun 2026
 View chart
Geode Capital Management 143k $1.1M 143% Jun 2026
 View chart
BlackRock 76k $564k 100% Jun 2026
 View chart
Vanguard Fiduciary Trust 67k $499k 92% Jun 2026
 View chart
FNY Investment Advisers 45k $330k 100% Jun 2026
 View chart
Federation des caisses Desjardins du Quebec 38k $283k -41% Jun 2026
 View chart
Northern Trust 28k $205k 100% Jun 2026
 View chart
Ethos Financial Group 25k $100k 0% Jun 2026
 View chart
State Street Corporation 17k $53k 0% Mar 2026
 View chart
Axxcess Wealth Management 14k $102k 100% Jun 2026
 View chart
Atlas Legacy Advisors 14k $102k 0% Jun 2026
 View chart
Equitable Holdings 10k $74k 100% Jun 2026
 View chart
UBS Group 6.4k $48k 100% Jun 2026
 View chart
SBI Securities 190.00 $1.4k 0% Jun 2026
 View chart
Caitong International Asset Management 7.00 $52.000200 100% Jun 2026
 View chart
Wells Fargo & Company 5.00 $37.000000 100% Jun 2026
 View chart

Who sold out of Lixte Biotechnology Holdings?

Fund or Company Name Date Sold Shares Held Valued At
Renaissance Technologies Mar 2026 93k $286k
Citadel Advisors Mar 2026 57k $174k
XTX Topco Mar 2026 23k $72k
Hrt Financial Mar 2026 11k $34k
Tower Research Capital Mar 2026 973.00 $3.0k